SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoca-Cola HBC Regulatory News (CCH)

Share Price Information for Coca-Cola HBC (CCH)

Share Price is delayed by 15 minutes
Get Live Data
4,586.00    58.00 (1.28%)
Bid:
4,568.00
Ask:
4,572.00
Spread: 4.00 (0.088%)
Market Cap: £16.71b
CCH Live PriceLast checked at - London Stock Exchange

Intraday Coca-Cola HBC Share Chart

Director/PDMR Shareholding

28 Mar 2024 17:55

RNS Number : 8114I
Coca-Cola HBC AG
28 March 2024

FOR IMMEDIATE RELEASE

28 March 2024

Coca-Cola HBC AG (the "Company")

Notification of transactions by Persons Discharging Managerial Responsibilities ("PDMRs')

The Company announces that, as a result of the satisfaction of performance conditions, the award granted on 12 September 2023 which was due to vest in March 2024 under the Company's Performance Share Award Plan ("PSP") vested on 27 March 2024 and has been transferred to the PDMR from shares held in treasury.

The following sets out the award that vested on 27 March 2024 and the number of shares sold following such vesting to cover taxes and other liabilities.

PDMR

Number of shares granted under the PSP vesting

Number of dividend equivalent shares

Number of shares sold to cover taxes and other liabilities

EBRU OZGEN

7,038

0

375

The Notification of Dealing Forms for the PDMR can be found below.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

EBRU OZGEN

2

Reason for the notification

a)

Position/status

CHIEF PEOPLE AND CULTURE OFFICER

b)

Initial notification /Amendment

INITIAL NOTIFICATION

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

COCA-COLA HBC AG

b)

LEI

549300EFP3TNG7JGVE49

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

CH0198251305

b)

Nature of the transaction

SHARES ISSUED TO PDMR FOLLOWING VESTING OF PERFORMANCE SHARE AWARD GRANTED IN SEPTEMBER 2023 WHICH WAS DUE TO VEST IN MARCH 2024 UNDER THE TERMS OF THE PSP. SHARES ISSUED BY A TRANSFER FROM SHARES HELD IN TREASURY

c)

Price(s) and volume(s)

Price(s)

Volume(s)

25.18843 GBP

7,038

d)

Aggregated information

- Aggregated volume

- Price

Price

Volume

Total

25.18843 GBP

7,038

177,276.17 GBP

e)

Date of the transaction

27 MARCH 2024

f)

Place of the transaction

XLON

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

COCA-COLA HBC AG ORDINARY SHARES OF CHF 6.70 EACH ("SHARES")

CH0198251305

b)

Nature of the transaction

SALE OF SHARES TO COVER TAX AND OTHER LIABILITIES ARISING FROM VESTING OF THE PERFORMANCE SHARE AWARD

c)

Price(s) and volume(s)

Price(s)

Volume(s)

25.18843 GBP

375

d)

Aggregated information

- Aggregated volume

- Price

Price

Volume

Total

25.18843 GBP

375

9,445.66 GBP

e)

Date of the transaction

27 MARCH 2024

f)

Place of the transaction

XLON

This notification is made in accordance with the requirements of the UK Market Abuse Regulation and EU Market Abuse Regulation.

For further information, please contact:

Jan Gustavsson

General Counsel and Company Secretary

+41 (0) 41 726 01 10

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHQKFBPOBKDBNB
Date   Source Headline
22nd May 20263:30 pmRNSDirector/PDMR Shareholding
19th May 20263:15 pmRNSDirector/PDMR Shareholding
11th May 20269:00 amRNSDirector Declaration
8th May 20263:15 pmRNSComposition of the Board Committees
8th May 20263:10 pmRNSResult of AGM
7th May 20267:00 amRNSStrong volume drives Q1 sales growth
20th Apr 20263:15 pmRNSDirector/PDMR Shareholding
14th Apr 202612:15 pmRNSNotice of Results
2nd Apr 20267:00 amRNSNotice of AGM, changes to the BoD, dividend dates
1st Apr 20269:15 amRNSTransfer of treasury shares & total voting rights
31st Mar 202611:00 amRNSPublication of Final Terms
27th Mar 20262:45 pmRNSDirector/PDMR Shareholding
27th Mar 20262:15 pmRNSDirector/PDMR Shareholding
26th Mar 20266:18 pmRNSPricing of Issue of Notes
26th Mar 20269:05 amRNSLaunch of Issue of Notes
25th Mar 20261:36 pmRNSPublication of a Prospectus
20th Mar 202611:00 amRNSAnnual Financial Report
19th Mar 20264:55 pmRNSDirector/PDMR Shareholding
19th Mar 20264:45 pmRNSDirector/PDMR Shareholding
18th Mar 20264:15 pmRNSDirector/PDMR Shareholding
18th Mar 202611:35 amRNSDirector/PDMR Shareholding
26th Feb 202611:30 amRNSDirector/PDMR Shareholding
25th Feb 20269:20 amRNSDirector/PDMR Shareholding
24th Feb 20264:55 pmRNSDirector/PDMR Shareholding
24th Feb 20264:50 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:40 pmRNSDirector/PDMR Shareholding
23rd Feb 20264:35 pmRNSDirector/PDMR Shareholding
18th Feb 20264:50 pmRNSDirector/PDMR Shareholding
18th Feb 20264:45 pmRNSDirector/PDMR Shareholding
18th Feb 20264:00 pmRNSDirector/PDMR Shareholding
17th Feb 20263:35 pmRNSDirector/PDMR Shareholding
17th Feb 20263:30 pmRNSDirector/PDMR Shareholding
16th Feb 20262:40 pmRNSDirector/PDMR Shareholding
16th Feb 20262:35 pmRNSDirector/PDMR Shareholding
13th Feb 202610:30 amRNSDirector/PDMR Shareholding
12th Feb 20263:45 pmRNSDirector/PDMR Shareholding
12th Feb 20261:15 pmRNSDirector/PDMR Shareholding
10th Feb 20267:00 amRNSStrong execution and financial performance in 2025
2nd Feb 202610:00 amRNSTransfer of treasury shares & total voting rights
19th Jan 20264:00 pmRNSDirector/PDMR Shareholding
19th Jan 20262:20 pmRNSResult of Extraordinary General Meeting
13th Jan 202611:00 amRNSNotice of Results
5th Jan 202610:00 amRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
23rd Dec 20252:45 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
22nd Dec 20252:15 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20255:00 pmRNSDirector/PDMR Shareholding
18th Dec 20253:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.